Skye Bioscience Inc (SKYE)

[cjarmstrong]

Speaking of facts and homework, in the presentation for CINV, on page 22 they list their source for ~70% bioavailability as 'Nemus Internal Data', but I found it in a research paper Elsohly co-authored from the early 1990s. I also read an interview (pre-Nemus) where he mentioned the suppository formulation was with a pharma. I know Elsohly is extracting THC to sell to Mallinckrodt to manufacture generic dronabinol. I assume that was the company he was referring to. I wonder why that ostensibly fell through.